Item 8.01 - Other Events

Wiley Announces Update on Health Condition of President and CEO Steve Smith John Wiley and Sons, Inc., today announced that its President and Chief Executive Officer, Stephen M. Smith, will undergo further treatment for urological cancer. Following surgery and chemotherapy a year ago Mr. Smith's doctors have recommended a further course of chemotherapy combined with radiation.

The treatment is planned to be carried out over the next two months, during which time Mr. Smith will continue to handle his day-to-day responsibilities as President and Chief Executive Officer. Whether in the office or working remotely, Steve will continue to work closely with the leadership team, as well as maintain regular communication with the Executive Committee of the Board of Directors, which includes Eduardo Menasce (Chair, Executive Compensation and Development Committee), Bill Plummer (Member of Audit Committee), Will Pesce (former President & CEO) and Peter Wiley (Chairman of the Board) regarding the progress of his treatment.

"We give Steve our full confidence as he receives further treatment and recovers from his illness," said Peter Booth Wiley, Chairman of the Board of Directors.

---